Join us for an insightful session IQVIA experts Anthony Mikulaschek and Michael Bruhns will share their experience on harnessing the power of eCOA and digital endpoint collecting devices to advance obesity trials.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/digital-endpoint-technologies
Event overview:
In the evolving landscape of clinical trials, the integration of electronic clinical outcome assessments (eCOA) and digital endpoints such as weight and body composition, actigraphy, and sleepscales are revolutionizing the approach to obesity research.
In this webinar, IQVIA experts Anthony Mikulaschek and Michael Bruhns will explore how these technologies can synergistically work together to provide more comprehensive and accurate data, ultimately leading to better outcomes in obesity trials. Join us for an insightful session where these industry experts will share their experience harnessing the power of eCOA and digital endpoint collecting devices to advance obesity trials.
Three key take-aways
- Integration Strategies: Discuss how eCOA can be seamlessly integrated with devices to enhance data collection, improve patient compliance, and streamline trial processes
- Use Cases and Outcomes: Review use cases that demonstrate implementation of these technologies in obesity trials and improvements in data accuracy and patient outcomes
- Future Directions: Identify emerging trends and future opportunities for leveraging eCOA and digital endpoint technologies to optimize obesity research and treatment strategies
Speakers:
Anthony Mikulaschek
Vice President, Patient Commercial Strategy
IQVIA
As vice president of DPS Patient Commercial Strategy at IQVIA, Anthony Mikulaschek manages all commercial aspects of the IQVIA Patient Suite of applications including eCOA, IRT, and eConsent. Previously, he was the VP of eCOA Operations for 6 years. Mikulaschek has extensive experience in validated system implementation, systems integration, business process reengineering, IT operations, and consulting. He has successfully led the development, delivery, and management of technology solutions for over 37 years, including 30 years in the pharmaceutical sector.
Michael Bruhns
Senior Director and Commercial Lead, Device Strategy
IQVIA Connected Devices
Michael Bruhns is the senior director at IQVIA for connected devices. He oversees commercial operations, strategic device partnerships, and global logistics. Bruhns’s 20+ years of experience span various industries. He is passionate about developing optimized digital endpoint strategies and creating win-win partnerships to build the broadest, most innovative portfolio of medical-grade devices for use in global clinical research across all service lines, modalities, and therapeutic areas.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/digital-endpoint-technologies